Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents

✍ Scribed by William J. Valentine; Andrew J. Palmer; Morten Lammert; Jakob Langer; Michael Brändle

• Book ID: 113544494
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 505 KB
• Volume: 33
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2011.09.022